Иммуногистохимическое исследование эпителия и показателей иммунной защиты при плоскоклеточных интраэпителиальных поражениях шейки матки
Диссертация
Плоскоклеточные интраэпителиальные поражения (англ. Squamous intraepithelial lesion — SIL) или цервикальная интраэпителиальная неоплазия (англ. cervical intraepithelial neoplasia — CIN) предшествуют плоскоклеточному раку шейки матки, составляющему 12% всех злокачественных опухолей женщин и занимающему второе место в мире среди наиболее частых гинекологических поражений. Как известно… Читать ещё >
Список литературы
- Аветисян Т.Г. Репродуктивная функция женщин после лечения заболеваний шейки матки. Автореф. Дисс. канд. мед. наук М. — 2008 — с. 32
- Аксель Е.М. Статистика злокачественных новообразований женских половых органов// В кн. Клиническая онкология под редакцией Козаченко В. П. -М.-2005- с. 9−17
- Андреев. А.И. Возможности методов цитологического в и гистологического исследования диагностике плоских кондилом шейки матки. //Акушерство и гинекология// -1990 № 2 — с.35−38
- Бебнева Т.Н., Прилепская В. Н. Папилломавирусная инфекция и патология шейки матки//Гинекология: Журнал для практических врачей 2001 — Том 3 -№ 3 —с. 77−81
- Волгарева Г. М., Завалишина Л. Э., Андреева Ю. Ю. и соавт. Экспрессия белка р16 в клетках некоторых распространенных форм рака//Архив патологии 2004 — № 5 — с. 3−5
- Гланц С. Медико-биологическая статистика (пер. с англ.) М.: Практика — 1999−459 с
- Голованова В.А., Новик В. И., Гуркин Ю. А. Папилломовирусная инфекция и патология шейки матки//Вопр. онкол. 1999 — № 45 (6) — 623−626
- Гусейнова М.Г. Пролиферативная активность эпителиального пласта экзо-и эндоцервикса при фоновых заболеваниях шейки матки у больных репродуктивного периода. Автореф. дисс. канд. мед. наук. М. — 2005 — с. 27
- Далленбах-Хеллвег Г., Трунк М. Й., Кнебель Дебериц М. Традиционные и новые молекулярные методы для ранней детекции рака шейки матки//Архив патологии 2004 — № 5 — с. 35−39
- Дамиров М.М. Лазерные, криогенные и радиоволновые технологии в гинекологии // Современные технологии в диагностике и лечении гинекологических заболеваний: научное издание.— М.: Пантори — 2004 — с. 273−274
- Киселев В.И., Киселев О. И. Этиологическая роль вируса папилломы человека в развитии рака шейки матки: генетические и патогенетические механизмы // Цитокины и воспаление, 2003 т.2. — № 4. — с. 31−38
- Коломиец Л.А., Уразова Л. Н. Генитальная папилломавирусная инфекция и рак шейки матки. Томск: Изд-во НТЛ, 2002 — 100 с
- Кондриков Н.И. Современные классификации заболеваний шейки матки // В кн.: Заболевания шейки матки, влагалища и вульвы. М.: Медпресс, 1999 — с.21−24
- Кондриков Н.И. Патология матки//Иллюстрированное руководство М.: Практическая медицина — 2008 — 334 с
- Козаченко A.B. Микрокарцинома шейки матки: клиника, диагностика, лечение. Автореф. Дис.. .докт. Мед. Наук. М., 2006 — с. 32
- Козуб Н.И., Козуб М. Н. Тіервьтй опыт использования радиоволновой энергии при лечении гинекологических больных//Международный медицинский журнал 2010 — № 2 — с. 41−43
- Кравинская Т.А. Результаты лечения доброкачественных заболеваний шейки матки в условиях высокой нагрузки ВПЧ // Современные технологии вдиагностике и лечении гинекологических заболеваний: научное издание.— М.: Пантори, 2009.— с. 106
- Минкина Г. Н. Плоскоклеточные интраэпителиальные поражения шейки матки: Автореф. дисс. док. мед. наук. — М.: 1999. 46 с
- Минкина Г. Н., Манухин И. Б., Франк Г. А. Предрак шейки матки. М.: Аэрограф-медиа, 2001. — 112 с
- Минкина Г. Н. Предраковые заболевания шейки матки: диагностика и лечение // Качество жизни. Медицина, 2004. № 3(6) — с. 32−34
- Могиревская О.А., Ежова JI.C., Асатурова А. В., Семенова Т. Б. Трудности интерпретации незрелой плоскоклеточной метаплазии при исследовании шеечных мазков. Материалы IV Регионального научного форума «Мать и дитя» 28−30 июня Екатеринбург, с. 200−201
- Прилепская В.Н. Генитальные инфекции и патология шейки матки. Клинические лекции / В. Н. Прилепская, Е. Б. Рудакова. — Омск: ИПЦ ОмГМА, 2004.-212 с
- Прилепская В.Н. Заболевания шейки матки, влагалища и вульвы / В. Н. Прилепская. М.: МЕД пресс-информ, 2005. — 432 с
- Прилепская В.Н. Вирус папилломы человека: современный взгляд на проблему / В. Н. Прилепская // Медицинский вестник. — 2007. № 29 (414). — с. 9−10
- Роговская С.И., Папилломавирусная инфекция у женщин и патология шейки матки: руководство для практикующего врача. — М.: ГЭОТАР-Медиа, 2005.- 144 с
- Стрижаков А.Н., Давыдов А. И., Белоцерковцева Л. Д. Клиническая кольпоскопия. М.: Медицина, 2002. — 91 с
- Aberle H., Schwartz H., Kemler R. Cadherin-catenin complex: protein interactions and their implications for cadherin function//J. Cell Biochem. 1996 -Vol. 61-p. 514−523
- ACOG Cervical cytologyrevaluation and management of abnormalities. ACOG Technical Bulletin, Washington DC, 1993
- Allen M., Kalantari M., Ylitalo N., et al. HLA DQ-DR haplotype and susceptibility to cervical carcinoma: indications of increased risk for development of cervical carcinoma in individuals infected with HPV18//Tissue Antigens 1996 -Vol. 48-p. 32−37
- Andersson J., Behbahani H., Lieberman J., et al. Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection//AIDS 1999 — Vol. 13 — p. 129 513 030
- Apple R.J., Becker T.M., Wheeler C.M., et al. Comparison of human leukocyte antigen DR-DQ1 disease associations found with cervical dysplasia and invasive cervical carcinoma//J. Natl. Cancer Inst. 1995 — Vol. 87 — p. 427−436
- Baak J.P.A., Kruse A.J., Garland S.M., et al. Combined p53 and retinoblastoma protein detection identify persistent and regressive cervical high-grade squamous intraepithelial lesions//Am. J. Surg. Pathol. 2005 — Vol. 29 — p. 1062−1066
- Baak J.P.A., Kruse A.J., Robboy S.J. Dynamic behavioural interpretation of cervical biomarkers intraepithelial neoplasia (CIN) by molecular biomarkers// J. Clin. Pathol.-2006-Vol. 59-p. 1017−1028
- Ballas Z.K., Turner J.M., Turner D.A., et al. A patient with simultaneous absence of «classical» natural killer cells (CD3-, CD16+, and NKH1+) and expansion of CD3+, CD4-, CD8-, NKH1+ subset//! Allergy Clin. Immunol. 1990 -Vol. 85-p. 453−459
- Barbosa M.S., Edwards C., Fisher C., et al The region of the HPV E7 oncoprotein homologous to adenovirus El A and SV40 large T antigen contains separate domains for Rb binding and casein kinase IIphosphorylation//EMBO 1990 -Vol. J9 — p. 153−160
- Bauer H.M., Ting Y., Greer C.E., et al Genital human papillomavirus infection in female university students as determined by a PCR-based method//JAMA — 1991 — Vol. 265-p. 471−477
- Bechtold V., Beard P., Raj K. Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA//J. Virol. — 2003 Vol. 77 — p. 2021−2028
- Bedell M.A., Hudson J.B., Golub T.R., et al. Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation//.!. Virol. — 1991 Vol. 65 — p. 2254−2260
- Bedell M.A., Jones K.H., Laimins L.A. The E6-E7 region of human papillomavirus type 18 is sufficient for transformation of NIH 3T3 and rat-1 cells//J. Virol.-1987-Vol. 61 p. 3635−3640
- Bell M.C., Edwards R.P., Partridge E.E., et al. CD8+ T lymphocytes are recruited to neoplastic cervix//J. Clin. Immunol. — 1995 Vol. 15(3) — p. 130−136
- Bell M.C., Schmidt-Grimminger D., Turbat-Herrera E., et al. HIV+ patients have increased lymphocyte infiltrates in CIN lesions//Gynecol. Oncol. — 2000 — Vol. 76-p. 315−319
- Bequet-Romero M., Lopez-Ocejo O. Angiogenesis modulator expression in culture cell lines positive for HPV-16 oncoproteins/ZBiochem. Biophys. Res. Commun. 2000 — Vol. 277 — p. 55−61
- Bergers G., Brekken R., McMahon G., et al. Matrix metalloproteinase-9 triggers the angiongenic switch during carcionogenesis//Nature Cell Biol. 2000 — Vol. 2 — p. 737−744
- Bernard B.A., Bailly C., Lenoir M.C., et al. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes//J. Virol. 1989 — Vol. 63 — p. 4317−4324
- Bibbo M., Dytch H.E., Alenghat E., et al. DNA ploidy profiles as prognostic indicators in CIN lesions// Am. J. Clin. Pathol. 1989 — Vol. 92 — p. 261−265
- Bingle L., Brown N.J., Lewis C.E. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies//! Pathol. 2002 -Vol. 196(3)-p. 254−265
- Birchmeier W., Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness/ZBiochim. Biophys. Acta-1994-Vol. 1198-p. 11−26
- Bontkes H.J., Van Duin M., deGruijl T.D., et al. HPV 16 infection and progression of cervical intraepithelial neopla- sia: analysis of HLA polymorphism and HPV 16 E6 sequences variants//Int. J. Cancer 1998 — Vol. 78 — p. 166−171
- Bosch F.X., Lorincz A., Munoz N., et al. The causal relation between human papillomavirus and cervical cancer// J. Clin. Pathol. — 2002 — Vol. 55 p. 244−265
- Branca M., Ciotti M., Santini D., et al. pl6INK4A expression is related to grade of CIN and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome//Int. J. Gynecol. Pathol. 2004 — Vol. 23 — p. 354−365
- Braun L., Durst M., Mikumo R., et al. Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor beta 1//Cancer Res. 1990 — Vol. 50 — p. 7324−7332
- Brinchmann J.E., Rosok B.I., Spurkland A. Activation and proliferation of CD8 T cells in lymphoid tissues of HIV-1-infected individuals in the absence of the high-affinity IL-2 receptor//! Acquir. Immune Defic. Syndr. 1998 — Vol. 19 — p. 332−338
- Broders A.C. Carcinoma in situ contrasted with benign penetrating epithelium//JAMA 1932 — Vol. 99 — p. 1670−1674
- Broker T.R. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias//Hum. Pathol. 1992 — Vol. 23 — p. 117−128
- Buckley C.H., Butler E.B., Fox H. Cervical intraepithelial neoplasia//.!. Clin. Pathol. 1982 — Vol. 35 — p. 1−13
- Burd E.M. Human papillomavirus and cervical cancer//Clin. Microbiol. Rew. -2003-Vol. 16-p. 1−17
- Burghardt E. Colposcopy-cervical pathology. Thieme Medical Publishers, New York 1991
- Caberg J.H., Hubert M., Begon D.Y., et al. Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes//Carcinogenesis 2008 — Vol. 29 -p. 1441−1447
- Carter J.J., Koutsky L.A., Wipf G.C., et al The natural history of human papillomavirus type 16 capsid antibodies aming a cohort of university women//J. Infect. Dis. 1996 — Vol. 174 — p. 927−936
- Chan W.K., Chong T., Bernard H.U., Klock G. Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promotors through API binding sites//Nucleic Acids Res. 1990 — Vol. 18 — p. 763 769
- Chen J.J., Reid C.E., Band V., et al. Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein// Science 1995 — Vol. 269 — p. 529−531
- Cheng S., Schmidt-Grimminger D.C., Murant T., et al. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes//Genes Dev. 1995 — Vol. 9 — p. 2335−2349
- Cheng W.F., Chen C.A., Lee C.N., et al. Vascular endothelial growth factor and prognosis of cervical carcinoma//Obstet. Gynecol. 2000 — Vol. 96 — p. 721−726
- Chung T.K., Cheung T.H., Lo W.K., et al. Loss of heterozygosity at the short arm of chromosome 3 in microdissected cervical intraepithelial neoplasia//Cancer Lett. 2000 — Vol. 154-p. 189−194
- Clarke B., Chetty R. Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer//J. Clin. Pathol: Mol. Pathol. 2002 — Vol. 55 — p.19−24
- Clement P.B., Young R.H. Atlas of gynecologic surgical pathology, 2008 Elsevier
- Cobrinik D., Dowdy S.F., Hinds P.W. The retinoblastoma protein and the regulation of cell cycling//Trends Biol. Sci. 1992 — Vol. 17 — p. 312−317
- Conacci-Sorrell M., Zhurinsky J., Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer// J. Clin. Invest. 2002 — 109 — p. 987−991
- Condeelis J., Pollard J.W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis// Cell 2006 — Vol. 124(2) — p. 263−266
- Conrad-Stoppler M.C., Ching K., Stoppler H., et al. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation//! Virol. 1996 — Vol. 70 — p. 69 876 993
- Coppleson M. The origin and nature of premalignant lesions of the cervix uteri//lnt. J. Gynecol. Obstet. 1970- Vol. 8 — p. 539−545
- Coussens L., Tinkle C., Hanahan D., et al. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis//Cell — 2000 — Vol. 103 p. 481−490
- Crook T., Morgenstern J.P., Crawford L., et al Continued expression of HPV 16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV 16 plus EJ-ras//EMBO J. 1989 — Vol. 8 — p. 513−518
- Cullen T.S. Cancer of the uterus//Appleton, New York 1900
- Dalstein V., Riethmuller D., Pretet J.L., et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study//Int. J. Cancer 2003 — Vol. 106 — p. 396−403
- Davidson B., Goldberg I., Kopolovic J. Inflammatory response in cervical intraepithelial neoplasia and squamous cell carcinoma of the uterine cervix//Pathol. Res. Pract. 1997 — Vol. 193(7) — p. 491-^95
- Dobbs S.P., Hewett P.W., Johnson I.R. et al Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia// Br. J. Cancer 1997-Vol. 76(11)-p. 1410−1415
- Dong X.P., Stubenrauch F., Beyer-Finkler E., et al. 1994. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers//Int. J. Cancer Vol. 58 — p. 803−808
- Dowhanick J.J., McBride A.A., Howley P.M. Suppression of cellular proliferation by the papillomavirus E2 protein//J. Virol. 1995 — Vol. 69 — p. 77 917 799
- Duensing S., Munger K. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability//Cancer Res. 2002 — Vol. 62 — p. 7075−7082
- Durst M., Glitz D., Schneider A., et al. Human papillomavirus type 16 (HPV16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization//Virology 1992 — Vol. 189 — p. 132−140
- Dyson N., Howley P.M., Munger K., et al The human papillomavirus 16 E7 oncoprotein is able to bind to the retinoblastoma gene product// Science — 1989 — Vol. 66-p. 1515−1522
- Edwards R.P., Kuykendall K., Crowley-Nowick P., et al. T lymphocytes infiltrating advanced grades of cervical neoplasia. CD8-positive cells are recruited to invasion//Cancer- 1995 Vol. 76(8)-p. 1411−1415
- Ellerbrock T.V., Chiasson M.A., Bush T.J., et al Incidence of cervical squamous intraepithelial lesions in HIV-infected women//JAMA 2000 — Vol. 283 -p. 1031−1037
- Evander M.I.H., Frazer E., Payne Y.M., et al. -Identification of the alpha 6 integrin as a candidate receptor for papillomaviruses//!.Virol. 1997 — Vol. 71 — p. 2449−2456
- Evans M., Borysiewicz L.K., Evans A.S., et al. Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6//J. Immunol. 2001 — Vol. 167 — p. 5420−5428
- Fadare O., Reddy H., Wang J., et al. E-cadherin and p-catenin expression in early stage cervical carcinoma: a tissue microarray study of 147 cases// World J. Surg. Oncol. 2005 — Vol. 3 — p. 38−46
- Faleiro-Rodrigues C., Lopes C. E-cadherin, CD44 and CD44v6 in squamous intraepithelial lesions and invasive carcinomas of the uterine cervix: an immunohistochemical study//Pathobiology 2004 — Vol. 71(6) — p. 329−336
- Felix J.C., Loiiky N.M., Tamura K., et al. Aberrant expression of E-cadherin in cervical intraepithelial neoplasia correlates with a false-negative Papanicolaou smear//Am. J. Obstet. Gynecol. 2002 — Vol. 186(6) — p. 1308−1314
- Fletcher S. Histopathology of papillomavirus infection of the cervix uteri: the history, taxonomy, nomenclature and reporting of koilocytic dysplasias//!. Clin. Pathol. 1983 — Vol. 36 — p. 616−624
- Follen M., Atkinson E.N., Schottenfeld D. A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix//Clin. Cancer Res. 2001 — Vol. 7 — p. 3356−3365
- Foote F.W., Stewart F.W. The anatomical distribution of intraepithelial epidermoid carcinomas of cervix//Cancer (Phila) 1948 — Vol. 1 — p. 431−440
- Fosslien E. Review: molecular pathology of cyclooxygenase-2 in cancerinduced angiogenesis//Ann. Clin. Lab. Sci. 2001 — Vol. 31 — p. 325−348
- Franquemont D.W., Ward B.E., Anderson W.A., et al. Prediction of «high-risk» cervical papillomavirus infection by biopsy morphology//Am. J. Clin. Pathol. 1989- Vol. 92 p. 577−582
- Friend S.H., Dryja T., Weinberg R.A. Oncogenes and tumor-suppressing genes//N. Engl. J. Med. 1988 — Vol. 318 — p. 618−622
- Fu Y.S., Braun L., Shah K.V., et al. Histologic nuclear DNA, and human papillomavirus studies of cervical condylomas//Cancer (Phila) 1983 — Vol. 52 — p. 1705−1711
- Fu Y.S., Huang I., Beaudenon S., et al. Correlative study of human papillomavirus DNA, histopathology and morphometry in cervical condyloma and intraepithelial neoplasia//Int. J. Gynecol. Pathol. 1988 — Vol. 7 — p. 297−307
- Fu Y.S., Reagan J.W., Richart R.M. Precursors of cervical cancer//Cancer Surv.- 1983-Vol. 2-p. 359−382
- Fujimoto J., Sakaguchi H., Aoki I., et al. Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers//Cancer Res. 2000 -Vol. 60(10) — p. 2632−2635
- Fujimoto J., Sakaguchi HI, Hirose R., et al. Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers//Br. J. Cancer 1999 -Vol. 80-p. 827−833
- Giannoudis A., Herrington C.S. Human papillomavirus variants and squamous neoplasia of the cervix//J. Pathol. 2001 — Vol. 193 — p. 295−302
- Giroglu T.L., Florin F., Schafer R.E., et al. Human papillomavirus infection requires cell surface heparin sulfate//J. Virol. 2001 — Vol. 75 — p. 1565−1570
- Gooding J.M., Yap K.L., Ikura M. The cadherin-catenin complex as a focal point of cell adhesion and signaling: new insights from three-dimensional structures//BioEssays 2004 — Vol. 26 p. 497−511
- Grieder C.W. Telomerase activation: one step on th road to cancer?//Trends Genet. 1999 — Vol. 15 — p. 109−112
- Hagen B., Skjeldestad F.E. A guide in gynecological oncology 2002
- Hajra K.M., Fearon E.R. Cadherin and Catenin alterations in human cancer//Genes, Chromosomes Cancer 2002 — Vol. 34 — p. 255−268
- Hammes L., Tekmal R., Naud P. et al. Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression—Clinicopathological correlation// Gynecol. Oncol. 2007 — Vol. 105 — p. 157−165
- Hanahan D., Weinberg R.A. The hallmarks of cancer//Cell 2000 — Vol. 100 -p. 57−70
- Hashimoto I., Kodama J., Seki N., et al. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer//Br. J. Cancer-2001 Vol. 85 p. 93−97
- Heatly M.K. How should we grade CIN?// Histopathology 2002 -Vol. 40 — p. 377−390
- Heller D.S., Hameed M., Cracchiolo B., et al. Presence and quantification of macrophages in squamous cell carcinoma of the cervix//Int. J. Gynecol. Cancer — 2003-Vol. 13(1)-p. 67−70
- Hering B., Horn L.C., Nenning H., et al. Predictive value of DNA cytometry in CIN1 and CIN2. Image analysis of 193 cases//Anal. Quant. Cytol. Hystol. 2000 -Vol. 22-p. 333−337
- Herman J.G., Merio A., Mao L., et al. Inactivation of the CDKN2/pl6MTSL gene is frequently associated with aberrant DNA methylation in all common human cancers//Cancer Res. -1995 Vol. 55 — p. 4525−4530
- Hernandez P., Merino N., Lopez-Ocejo O., et al. A mouse fibroblast cell model to study human papillomavirus associated tumorigenesis/ZBiochem. Biophys. Res. Commun. 2000 — Vol. 270 — p. 119−124
- Hildesheim A., Schiffman M., Bromley C., et al. Human papillomavirus type 16 variants and risk of cervical cancer//J. Natl. Cancer Inst. — 2001 — Vol. 93 — p. 315−318.
- Ho G.Y., Bierman R., Beardsley S., et al Natural history of cervicovaginal papillomavirus infrction in young women//N. Engl. J. Med. 1998 — Vol. 338 — p. 423−428
- Hwang E.S., Riese D.J. 2nd, Settleman J., et al. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene//J. Virol. 1993 — Vol. 67 — p. 3720−3729
- Iglesias M., Yen K., Gaiotti D., et al Human papillomavirus type 16 E7 protein sensitizes cervical kerationcytes to apoptosis and release of interleukin-1 alpha//Oncogene 1998 — Vol. 17 — p. 1195−1205
- Ismail S.M., Colelough A.B., Dinnen J.S., et al. Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia//Br. Med. J. 1989 — Vol. 298 — p. 707−710
- Jakobsen A., Kristensen P.B., Poulsen H.K. Flow cytometric classification of biopsy speciemens from cervical intraepithelial neoplasia//Cytometry 1983 — Vol. 4 -p. 166−169
- Jeon S., Allen-Hoffmann B.L., Lambert P.F. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells//J. Virol. 1995 — Vol. 69 — p. 2989−2997
- Johnson L.D. The histopathological approach to early cervical neoplasia//Obstet. Gynecol. Surv. 1969 — Vol. 24 — p. 735−767
- Josefsson A.M., Nagnusson P.K., Yitalo N., et al Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study//Lancet 2000 -Vol. 355 — p. 2189−2193
- Kalantari M., Blennow E., Hagmar B., et al. Physical state of HPV 16 and chromosomal mapping of the integrated form in cervical carcinomas//Diagn. Mol. Pathol. 2001 — Vol. 10 — p. 46−54
- Kalantari M., Karisen F., Johansson B., et al Human papillomavirus findings in relation to cervical intraepithelial neoplasia grade: a study on 476 Stockholm women, using per for detection and typing of HPV//Hum. Pathol. 1997 — Vol. 28 — p. 899 904
- Kaplanis K., Kiziridou A., Liberis V., et al E-cadherin expression during progression of squamous intraepithelial lesions in the uterine cervix//Eur. J. Gynaecol. Oncol. 2005 — Vol. 26(6) — p. 608−610
- Keating J.T., Cviko A., Reithdorf S., et al. Ki-67, cyclin E, and pl6INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia//Am. J. Surg. Pathol. 2001 — Vol. 25 — p. 884−891
- Kessis T.D., Connolly D.C., Hedrick L., et al. Expression of HPV16 E6 or E7 increases integration of foreign DNA//Oncogene 1996 — Vol. 13 — p. 427−431
- Kieser A., Weich H.A., Brandner G., et al. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression//Oncogene -1994-Vol. 9-p. 963−969
- Klaes R., Benner A., Friedrich T., et al. pl6INK4a immunohistochemistiyimproves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia//Am. J. Surg. Pathol. 2002 — Vol. 26 — p. 1389−1399
- Klaes R., Fridrich T., Spitkovsky D., et al Overexpression of pl6(INK4a) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri//Int. J. Cancer 2001 — Vol. 92 — p. 276−284
- Klaes R., Woerner S.M., Ridder R., et al. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes//Cancer Res. 1999 — Vol. 59 — p. 61 326 136
- Kleine-Lowinski K., Gillitzer R., Kuhne-Heid R., et al. Monocytechemo-attractant-protein-1 (MCP-l)-gene expression in cervical intraepithelial neoplasias and cervical carcinomas//Int. J. Cancer 1999 — 82(1) — p. 6−11
- Klingelhutz A.J., Foster S.A., McDougall J.K. Telomerase activation by the E6 gene product of human papillomavirus type 16//Nature 1996 — Vol. 380 — p. 79−82
- Kobayashi A., Darragh T., Herndier B-, et al- Lymphoid’follicles are generated in high-grade cervical dysplasia and have differing characteristics- depending on HIV staW/Am. J- Pathol.-2002−160(1) — p. 151−164 •
- Kobayashi A., Greenblatt R.M., Anastos K., et al. Functional attributes of mucosal- immunity in cervical intraepithelial neoplasia and? effects of HIV infection//Cancer Res.-2004-Vol. 64-p. 6766−6774
- Kodama J., Seki N. Tokumo K., et al. Vascular endothelial- growth- factor is implicated in early invasion in cervical cancer//Eur. J. Cancer 1999 — Vol. 35 — p. 485−489
- Kolstad P., Klem V. Long-term follow-up. of 1121 cases of carcinoma in situ//Obstet. Gynecol. 1979 — Vol. 48 — p. 125−133.
- Koss L.G. Diagnostic cytology and its histopathologic basis//4th ed. Lippincott, Philadelphia 1978 — p. 383−387
- Koss L. G-, Stewart F.W., Foote F.W., et al. Some histological aspects of behavior of epidermoid carcinoma in situ and related lesions of the uterine cervix//Cancer (Phila) 1963 — Vol. 16 — p. 1160−1211
- Kruse A.J., Baak J.P., de Bruin P.C., et al. Ki-67 immunoquantitation in cervical intraepithelial neoplasia (CIN): a sensitive marker for grading//J. Pathol. -2001 -Vol. 193-p. 48−54
- Kruse A J., Baak J.P., Helliesen T., et al. Evaluation of KI-67-positive cell clusters as a diagnostic marker for cervical intraepithelial neoplasia//Am. J. Surg. Pathol. 2002 — Vol. 26 — p. 1501−1507
- Kuo K.T., Chang H.C., Hsiao C.H. et al. Increased ki-67 proliferative index and absence of pl6INK4a in CIN-HPV related pathogenic pathways different from cervical squamous intraepithelial lesion//Br. J. Ophthalmol. 2006 — Vol. 90 — p. 894−899
- Kuss I., Donnenberg A.D., Gooding W., et al. Effector CD8+ CD45RO+CD27+ T cells have signalling defects in patients with squamous cell carcinoma of the head and neck//Br. J. Cancer 2003 — Vol. 88 (2) — p. 223−230
- Kyo S., Inoue M., Hayasaka N., et al. Regulation of early gene expression of human papillomavirus type 16 by inflammatory cytokines//Virology 1994 — Vol. 200-p. 130−139
- Larson A.A., Kern S., Cutriss S., et al High resolution analysis of chromosome 3p alterations in cervical carcinoma//Cancer Res. 1997 — Vol. 57 — p. 4082−4090
- Lee B.N., Folien M., Tortolero-Luna G., et al. Synthesis of IFN-gamma by CD8(+) T cells is preserved in HIV-infected women with HPV-related cervical squamous intraepithelial lesions//Gynecol. Oncol. 1999 — Vol. 75 — p. 379−386
- Lee D., Kim H.Z., Jeong K.W., et al. Human papillomavirus E2 down-regulates the human telomerase reverse transcriptase promoter//J. Biol. Chem. 2002 — Vol. 277 — p. 27 748−27 756
- Lee I.J., Park K.R., Lee K.K., et al. Prognostic value of vascular endothelial growth factor in stage IB carcinoma of the uterine cervix//Int. J. Radiat. Oncol. Biol. Phys. 2002 — Vol. 54 — p. 768−679
- Lee J.S., Kim H.S., Jung J.J., et al. Expression of vascular endothelial growth factor in adenocarcinomas of the uterine cervix and its relation to angiogenesis and p53 and c-erbB-2 protein expression//Gynecol. Oncol. 2002 — Vol. 85 — p. 469−675
- Lee J.S., Kim H.S., Park J.T., et al. Expression of vascular endothelial growth factor in the progression of cervical neoplasia and its relation to angiogenesis and p53 status//Anal. Quant. Cytol. Histol. 2003 — Vol. 25 — p. 303−311
- Lehn H., Villa L.L., Marziona F., et al. Physical state and biological activity of human papillomavirus genomes in precancerous lesions of the female genital tract//J. Gen. Virol. 1988 — Vol. 69 — p. 187−196
- Lewis C.E., Pollard J.W. Distinct role of macrophages in different tumor microenvironments//Cancer Res. 2006 — Vol. 66(2) — p. 605−612
- Li Y., Nicolas M.A., Shay J.W. et al. Transriptional repression of the D-type cyclin dependent kinase inhibitor pl6 by retinoblastoma susceptibility gene product pRb//Canere Res. 1994 — Vol. 54 — p. 6078−6082
- Luff R.D. The Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda Workshop//Hum. Pathol. 1992 — Vol. 23 -p. 719−721
- Lungy O., Sun X.W., Felix J., et al. Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia//JAMA 1992 — Vol. 267 — p. 24 932 493
- Magal S.S., Jackman A., Pei X.F., et al. Induction of apoptosis in human kerationcytes containing mutated p53 alleles’and its inhibition by both the E6 and E7 oncoproteins//Int. J. Cancer 1998 — Vol. 75 — p. 96−104
- Matzner I., Savelyeva L., Schwab M. Preferential integration of a transfected marker gene into spontaneously expressed fragile sites of a breast cancer cell line//Cancer Lett. 2003 — Vol. 189 — p. 207−219
- May M., Dong X.P., Beyer-Finkler E., et al. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1//EMBO J. 1994 — Vol. 13 — p. 1460−1466
- Mazibrada J., Ritta I., Mondini M., et al. Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis//Gynecologic Oncology 2008 — Vol. 108 — p. 112−120
- Mazure N.M., Chen E.Y., Yeh P., et al. Oncogenic Transformation and Hypoxia Synergistically Act to Modulate Vascular Endothelial Growth Factor Expression//Cancer Res. 1996 — Vol. 56 — p. 3436−3440
- Meisels A., Fortin R. Condylomatous lesions of the cervix and vagina. I. Cytologic patterns//Acta Cytol. 1976 — Vol. 20 — p. 505−509
- Meisels A., Morin C., Casas-Cordero M. Humanpapillomavirus infection of the uterine cervix//Int. J. Gynecol. Pathol. 1982 — Vol. 1 — p. 75−94
- Meisels A., Roy M., Fortier M., et al. Condylomatous lesions of the cervix: morphologic and colposcopic diagnosis//Am. J. Diagn. Gynecol. Obstet. — 1979 -Vol. 1-p. 75−94
- Meyskens F.L., Surwit E., Moon T.E. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with- topically applied all-transretinoic acid: a randomized trial//J. Natl. Cancer Inst. — 1994 Vol. 86 — p. 539 543
- Moscicki A.B., Shiboski S., Broering J., et al The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women//! Pediatr. 1998 — Vol. 132 — p. 277−284
- Mourits M.J.E., Pieters W.J., Hollema H., et al Three-group metaphase as a morphologic criterion of progressive cervical intraepithelial neoplasia//Am. J. Obstet. Gynecol. -1992-Vol. 167-p. 591−595
- Munger K., Baldwin A., Edwards K.M., et al. Mechanisms of human papillomavirus-induced oncogenesis//!. Virol. 2004 — Vol. 78 — p. l 1451−11 460
- Murdoch C., Lewis C.E. Macrophage migration and gene expression in response to tumor hypoxia//Int. J. Cancer 2005 — Vol. 117(5) — p. 701−708
- Nagafuchi A. Molecular architecture of adherens junctions//Curr. Opin. Cell Biol. 2001 — Vol. 13 — p. 600−603
- NCI Nationao Cancer Instiute Workshop: the 1988 Bethesda system for reporting cervical/vaginal cytologic diagnoses//JAMA 1989 — Vol. 262 — p. 931−934
- Nedergaard B.S., Ladekarl M., Thomsen H.F., et al. Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer //Brit. J. Cancer 2007 — Vol. 97 — p. l 135−1138
- Negri G., Vittadello F., Romano F., et al. pl6INK4a overexpression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri// Virchows Arch. 2004 — Vol. 445 — p- 616−620
- Nelson W.J., Nusse R: Convergence of Wnt, ?-Catenin, and Cadherin pathways//Science 2004 — Vol. 303 — p. 1483−1487
- Obermair A., Bancher-Todesca D., Bilgi S., et al. Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia//! Natl. Cancer Inst. 1997 — Vol. 89 — p.1212−1217
- O’Brien P.M., Saveria C.M. Evasion of host immunity directed by papillomavirus-encoded proteins//Virus Res. 2002 — Vol. 88 — p. 103−117
- O’Connor M.J., Stunkel W., Koh C.H., et al. The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element//J. Virol. 2000 — Vol. 74 — p. 401410
- Oda H., Kumar S., Howley P.M. Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination//Proc. Natl. Acad. Sei. USA 1999 — Vol. 96 — p. 9557−9562
- Omori M., Nakazawa A., Yuminamichi T., et al. Estimation of prognoses for cervical intraepithelial neplasia 2 by pl6INK4a immunoexpression and high-risk HPV in situ hybrbidization signal types// Am. J. Clin.-Pathol. 2007 — Vol. 128 — p. 208−217
- Ordi J., Garcia S., del Pino M., et al. pl6INK4a Immunostaining Identifies Occult CIN Lesions in HPV-positive Women// Int. J. Gynecol. Pathol. -2009 Vol. 28, No. 1-p. 90−97
- Ostor A.G. Natural history of cervical intraepithelial neoplasia: a critical review// Int. J. Gynecol. Pathol. 1993 — Vol. 12 — p. 186−192
- Park T.J., Richart R.M., Sun X.W., et al Association between HPV type and clonal status of cervical squanous intraepithelial lesions (SIL)//J. Natl. Cancer Inst. -1996-Vol. 88-p. 355−358
- Parker J.N., Zhao W., Askins K.J., et al. Mutational analyses of differentiation-dependent human papillomavirus type 18 enhancer elements in epithelial raft cultures of neonatal foreskin keratinocytes//Cell Growth Differ. 1997 Vol. 8 — p. 751—762
- Parker M.F., Zahn C.M., Vogel K.M., et al. Discrepancy in the interpretation of cervical histology by gynecologic pathologists//Obstet. Gynecol. 2002 — Vol. 100 -p. 277−280
- Parkin D.M., Bray F. Chapter 2: the burden of HPV-related cancers//Vaccine -2006 Vol. 24 — Suppl 3 — S11-S25
- Peitsaro P., Johansson B., Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique//J. Clin. Microbiol. 2002 — Vol. 40 — p. 886 891
- Pemberton F.A., Smith G.V. The early diagnosis and prevention of carcinoma of the cervix: a clinical pathologic study of borderline cases treated at the Free Hospital for women//Am. J. Obstet. Gynecol. 1929 — Vol. 17 — p. 165−167
- Pett M.R., Alazawi W.O., Roberts I., et al. Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes//Cancer Res. 2004 — Vol. 64 — p. 1359−1368
- Pett M.R., Coleman N. Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis?/^. Pathol. 2007 — Vol. 212 — p. 356−367
- Pett M.R., Herdman M.T., Palmer R.D., et al. Selection of cervical keratinocytes containing integrated HPVI6 associates with episome loss and an endogenous antiviral response/ZProc. Natl. Acad. Sci. USA 2006 — Vol. 103 — p. 3822−3827
- Phelps W.C., Yee C.L., Mynger K., et al. The human papillomavirus type 16 E7 gene encodes transactivation and transforming functions similar to those of adenovirus El A//Cell 1988 — Vol. 58 — p. 539−547
- Pieters W.J., Koudstaal J., Ploem-Zaajer J.J., et al The three group metaphase as morphologic indicator of high ploidy cells in cervical intraepithelial neoplasia//Anal. Quant. Cytol. Histol. 1992 — Vol. 14 — p. 227−232
- Przybora L.A., Plutowa A. Histological topography of carcinoma in situ of cervix uteri//Cancer (Phila) 1959 — Vol. 12 — p. 263−277
- Quint W.G.V., Scholte G., Van Doom L.J., et al. Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF10 PGR and HPV genotyping//J. Pathol. 2001 — Vol. 194 — p. 51−58
- Ravi R, Mookerjee B., Bhujwalla Z.M., et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor la// Genes Dev -2000-Vol. 14-p. 34−44
- Reagan J.W., Hamonic M.J. Dysplasia of the uterine’cervix//Ann. NY Acad. Sci. 1956 — Vol. 63 — p. 662−682
- Reagan J.W., Ng A.B.P., Wentz W.B. Concepts of genesis and development in early cervical neoplasia//Obstet. Gynecol. Surv. 1969- Vol.' 24 — p. 860−874
- Richart M. Colpomicroscopic studies of the distribution of dysplasia and carcimoma in situ 'on the exposed portion of the human uterine cervix//Cancer (Phila) — 1965-Vol. 18-p. 950957
- Richart R.M. Cervical intraepithelial neoplasia: a review//In: Sommers SC (ed) Pathology annual. Appleton-Century-Crofts, East Norwalk, 1973 — p. 301−328
- Richart R.M. A modified terminology for cervical intraepithelial neoplasia//Obstet. Gynecol. 1990 — Vol. 75 — p. 131−133
- Richart R.M., Lerch V., Baron B. A time-lapse cinematographic study in vitro of mitosis in mormal human cervical epithelium, dysplasia and carcinoma in situ//J. Natl. Cancer Inst. 1967 — Vol. 39 — p. 571−586
- Richart R.M., Wright T.C. Controversies in the management of low grade cervical intraepithelial neoplasia//Cancer (Phila) 1993 — Vol. 71 — p. 1413−1421
- Riethdorf S., Riethdorf L., Richter N., et al. Expression of the MCP-1 gene and the HPV 16 E6/E7 oncogenes in squamous cell carcinomas of the cervix uteri and metastases/ZPathobiology 1998 — Vol. 66(6) — p. 260−267
- Robertson A.J., Anderson J.M., Beck J.S., et al. Observer variability inhistopathological reporting of cervical biopsy specimens//.!. Clin. Pathol. 1989 -Vol. 42-p. 231−238
- Romanczuk H., Thierry F., Howley P.M. Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 PI05 promoters//.!. Virol. 1990 — Vol. 64 — p. 2849−2859
- Rosl F., Lengert M., Albrecht J., et al. Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids//! Virol. 1994 — Vol. 68 — p. 2142−2150
- Sadlar L., Saftlas A., Wang W., et al. Treatment for cervical intraepithelial neoplasia and risk of preterm delivery//JAMA 2004 — Vol. 291 — p. 2100−2106
- Sano T., Oyama T., Kashiwabara K., et al. Expression status of pi 6 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions// Am. J. Pathol. 1998 — Vol. 153 — p. 1741−1748
- Schwartz S. Regulation of human papillomavirus late gene expression//Ups. J. Med. Sci.-2000-Vol. 105-p. 171−192
- Sheu B.C., Hsu S.M., Ho H.N., et al. Reversed CD4/CD8 Ratios of Tumor-Infiltrating Lymphocytes Are Correlated with the Progression of Human Cervical Carcinoma // Cancer 1999 — Vol. 86 — № 8 — p. 1537−1543
- Shingleton H.M., Richart R.M., Wiener J., et al Human cervical intraepithelial neoplasia. Fine structure of dysplasia and carcinoma in situ//Cancer Res. 1968 -Vol: 28-p. 695−706
- Smith J.W., Townsend D.E., Spark R.S. Genetic variants of glucoses-phosphate dehydrogenase in th study of carcinoma of the cervix//Cancer (Phila) — 1971-Vol. 28-p. 529−532
- Soufla G., Sifakis S., Baritaki S., et al. VEGF, FGF2, TGF. l and TGF. R1 mRNA expression levels correlate with the malignant transformation of the uterine cervix//Cancer Lett. 2005 — Vol. 221 — p. 105−118
- Southern S.A., Herrington C.S. Disruption of cell cycle control by human papillomaviruses with special reference to cervical carcinoma//Int. J. Gynecol. Cancer 2000 — Vol. 10 — p. 263−274
- Spriggs A.I., Bowey C.E., Cowdell R.H. Chromosomes of precancerous lesions of the cervix uteri//Cancer (Phila) 1971 — Vol. 27 — p. 1239−1243
- Stanley M.A., Browne H.M., Appleby M., et al. Properties of a non-tumorigenic human cervical keratinocyte cell line//Int. J. Cancer 1989 — Vol. 43 — p. 672−676
- Stoler M.H., Rhodes C.R., Whitbeck A., et al. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias//Hum. Pathol. 1992 — Vol. 23 — p. 117−128
- Sun X.W., Kuhn L., Ellerbrock T.V., et al Human papillomavirus infection in HIV-seropositive women- natural history and variability of detection//N. Engl. J. Med.-1997-Vol. 337-p. 1343−1349
- Swan D.C., Tucker R.A., Tortolero-Luna G., et al. Human papilloma (HPV) DNA copy number is dependent on grade of cervical disease and HPV type//J. Clin. Microbiol. 1999 — Vol. 37 — p. 1030−1034
- Takeichi M. Morphogenetic roles of classic cadherins//Curr. Opin. Cell Biol. -1995-Vol. 7-p. 619−627
- Talmage D.A., Freund R., Dubensky T., et al. Heterogeneity in state and expression of viral DNA in polyoma virus-induced tumors of the mouse//Virology -1992 Vol. 187 — p. 734−747
- Tay S.K., Jenkins D., Maddox P., et al. Lymphocyte phenotypes in cervical intraepithelial neoplasia and human papillomavirus infection//Br. J. Obstet. Gynaecol.- 1987 Vol. 94(1) — p. 16 — 21
- Thomas M., Banks L. Inhibition of Bak-induced apoptosis by HPV-18 E6//Oncogene 1998 — Vol. 17 — p. 2943−2954
- Thorland E.C., Myers S.L., Gostout B.S., et al. Common fragile sites are preferential targets for HPV16 integrations in cervical tumors//Oncogene 2003 -Vol. 22-p. 1225−1237
- Thorland E.C., Myers S.L., Persing D.H., et al. Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites//Cancer Res.- 2000 Vol. 60 — p. 5916−5921
- Tjalma W., Weyler J., Weyn B., et al. The association between vascular endothelial growth factor, microvessel density and clinicopathological features in invasive cervical cancer//Eur. J. Obstet. Gynecol.-Reprod. Biol. 2000 — Vol. 92 — p. 251−257
- Tong X., Howley P.M. The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton//Proc. Natl. Acad. Sei. USA 1997 -Vol. 94-p. 4412−4417'
- Tonon S.A., Picconi M.A., Bos P.D., et al. Physical status of the E2 human papilloma virus 16 viral gene in cervical preneoplastic and neoplastic lesions//J. Clin. Virol. 2001 — Vol. 21 — p. 129−134
- Trimble C.L., Piantadosi S., Gravitt P., et al. Spontaneous regression of highgrade cervical dysplasia: effects of human papillomavirus type and HLA phenotype//Clin. Cancer Res. 2005 — Vol. 11 — p. 4717−4723
- Tsoumpou I., Arbyn M., Kyrgiou M., et al. P16INK4a immunostaining in cytological and histological speciemens from the uterine cervix: A systematic review and meta-analysis //Cancer Treatment Rev. 2009 — Vol. 35 — p. 210−220
- Ueda M., Terai Y., Yamashita Y., et al. Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas//Int. J. Cancer 2002- Vol. 98 — p. 335−343
- Van Tine B.A., Kappes J.C., Banerjee N.S., et al. Clonal selection for transcriptionally active viral oncogenes during progression to cancer//J. Virol. 2004 -Vol. 78-p. 11 172−11 186
- Van Tine B.A., Knops J., Broker T.R., et al. In situ analysis of the transcriptional activity of integrated viral DNA using tyramide-FISH//Dev. Biol. -2001-Vol. 106-p. 381−385
- Van Trappen P.O., Steele D., Lowe D.G., et al. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during different stages of cervical carcinogenesis//!. Pathol. 2003 — Vol. 201 — p. 544−554
- Veldman T., Horikawa I., Barrett J.C., et al. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein//!. Virol. -2001 Vol. 75 — p. 4467−4472
- Verdu M., Roman R., Pubill C. Ki-67 and P16INK4a immunoexpression strongly correlates with increasing grade of CIN and HPV infection// Virchows Archiv 2008 — Vol. 452 — suppl. 1 — S82
- Veress G., Szarka K., Dong X.P., et al. Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16//J. Gen. Virol. 1999 — Vol. 80 — p. 1053−1043
- Volpert O.V., Dameron K.M., JBouck N. Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity//Oncogene -1997-Vol. 14-p. 1495−1502
- Wallin K.L., Wiklund F., Angstrom T., et al Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer//N. Engl. J. Med. 1999- Vol. 341 — p. 1633−1638
- Weid G.L. Proceedings of the First International Congress on Exfoliative Cytology-1961
- Wentzensen N., von Knebel Doeberitz M. Biomarders in cervical cancer screening.// Dis. Markers 2007 — Vol. 23 — p. 315−320
- Willett G.D., Kurman R.J., Reid R., et al. Correlation of the histological appearance of intraepithelial neoplasia of the cervix with human papillomavirus types/Ant. J. Gynecol. Pathol. 1989 — Vol. 8 — p. 18−25
- Williams J. Cancer of the uterus/ZHarveian lectures for 1886 1888
- Wright T.C., Kurman R.J. A critical review of the morapologic classificationsystems of preinvasive lesions of the cervix: the scientific basis of theparadign//Papillomavirus Rep. 1994 — Vol. 5 — p. 175−181 і
- Wright T.C., Kurman R.J. Precanceruos lesions of the cervix. In Blaustein’sfHpathology of the female genital tract — 5 ed. New York Berlin Heidelberg 2002 -p. 253−322
- Yee C., Krishnan-Hewlett I., Baker C.C., et al. Presence and’expression of human papillomavirus sequences in human cervical carcinoma cell lines//Am. J. Pathol. 1985 — Vol. 119 — p. 361−366
- Ylitalo N.,'Sorensen P., Josefsson A.M., et al Consistent high viral load of human papillomavirus 16 and risk of cervical carciomna in situ: a nested case-control study//Lancet 2000 — Vol. 355 — p. 2194−2198
- Zerbini M., Venturoli S., Cricca M., et al. Distribution and viral load of type specific HPVs in different cervical lesions as detected by PCR-ELISA//J. 'Clin. Pathol. 2001 — Vol. 54 — p. 377−380
- Zha S., Yegnasubramanian V., Nelson W.G., et al. Cyclooxygenases in cancer: progress and perspective—Role of COX-2 inhibitors in cancer therapy//Cancer Lett -2004-Vol. 215(1)-p. 1−20
- Zhao W., Chow L.T., Broker T.R. A distal element in the HPV-11 upstream regylatory region contributes to promoter repression in basal keratinocytes in squamous epithelium//Virology 1999 — Vol. 253 — p. 219−229
- Zhao W., Chow L.T., Broker T.R. Transcription activities of human papillomavirus type 11 E6 promoter-proximal elements in raft and submerged cultures of foreskin keratinocytes//J. Virol. 1997 Vol. 71 — p. 8832−8840
- Zhao W., Noya F., Chen W.Y., et al Trichostatin A up-regylatory region-E6 promoter activity in undifferentiated primary human keratinocytes//J. Virol. 1999 -Vol. 73-p. 5026−5033
- Zhou J., Liu W.J., Peng S.W., et al. Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability//! Virol. — 1999 Vol. 73 — p. 4972−4982